类有机物
生物
癌变
诱导多能干细胞
卵巢癌
生殖系
癌症研究
种系突变
癌症
移植
浆液性液体
突变
遗传学
内科学
基因
医学
胚胎干细胞
生物化学
作者
Nur Yucer,Rodney Ahdoot,Michael J. Workman,Alex Laperle,María Sol Recouvreux,Kathleen Kurowski,Diana J. Naboulsi,Victoria Liang,Ying Qu,Jasmine Plummer,Simon A. Gayther,Sandra Oršulić,Beth Y. Karlan,Clive Niels Svendsen
出处
期刊:Cell Reports
[Cell Press]
日期:2021-12-01
卷期号:37 (13): 110146-110146
被引量:57
标识
DOI:10.1016/j.celrep.2021.110146
摘要
Germline pathogenic mutations in BR east CA ncer ( BRCA1 ) genes are thought to drive normal fallopian tube epithelial (FTE) cell transformation to high-grade serous ovarian cancer. No human models capture the sequence of events for disease initiation and progression. Here, we generate induced pluripotent stem cells (iPSCs) from healthy individuals and young ovarian cancer patients with germline pathogenic BRCA1 mutations ( BRCA1 mut ). Following differentiation into FTE organoids, BRCA1 mut lines exhibit cellular abnormalities consistent with neoplastic transformation compared to controls. BRCA1 mut organoids show an increased production of cancer-specific proteins and survival following transplantation into mice. Organoids from women with the most aggressive ovarian cancer show the greatest pathology, indicating the potential value to predict clinical severity prior to disease onset. These human FTE organoids from BRCA1 mut carriers provide a faithful physiological in vitro model of FTE lesion generation and early carcinogenesis. This platform can be used for personalized mechanistic and drug screening studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI